![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 22, 2021 1:32:58 PM
JAMIE DUCHARME
It’s safe to say that before the development of the Pfizer-BioNTech and Moderna COVID-19 vaccines, most people hadn’t thought about messenger RNA, or mRNA, since high school science class—if ever.
The molecule plays a pivotal role in the body, carrying the recipes for making various proteins to the parts of cells that produce them. But “mRNA” wasn’t exactly a common phrase until Pfizer-BioNTech and Moderna harnessed the genetic material’s power to teach the body to make a piece of a protein found on the COVID-19 virus’ surface, thus training it to fight the real thing, were it to attack.
“COVID [vaccines are] a big success for mRNA, and if it does nothing else, it’s been great,” Chien says. “However, I think you’re going to see the next chapter of mRNA is going to be as exciting, if not more so, than the story of mRNA vaccines.”
https://apple.news/AFh8kLmxRRUKh82JMrSl6_g
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM